Ibutilide

Corvert

0.1 MG / ML SolutionCanadaMarketedAuthorised 28 Nov 2000

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

CorvertItaly · Soluzione per infusione · Pfizer Italia S.R.L.Same brand
Corvert 87 µg/ml, oplossing voor intraveneuze infusieNetherlands · Oplossing voor infusie · Pfizer B.V.Same brand
CorvertUnited States · 0.1MG/ML · injectable · PfizerSame brand
Ibutilide FumarateUnited States · 0.1MG/ML · injectable · Avet LifesciencesSame substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ibutilide

Corvert

0.1 MG / ML SolutionCanadaMarketedAuthorised 28 Nov 2000

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ibutilide
Strength: 0.1 MG / ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 28 Nov 2000
Registration: DIN 02242470
Marketing authorisation holder: Pfizer Canada Ulc
ATC code: C01BD05
Group: Cardiovascular system
Supply: PRESCRIPTION